XiFin Boosts AI-Powered RCM with New Growth Investment

XiFin, a leader in AI-driven RCM solutions, secured a new growth capital investment. Goldman Sachs External Investing Group co-led the round. Majority investor Avista Healthcare Partners also participated, alongside other institutional investors. The company did not disclose financial terms.

This funding will fuel XiFin's growth trajectory. Furthermore, it supports the development of its next-gen XiFin Empower platform. The company aims to capitalize on AI opportunities within the healthcare RCM sector. XiFin previously achieved 19% year-over-year growth.

Accelerating Healthcare RCM Innovation

XiFin additionally welcomed Jeff Margolis to its Board of Directors. Margolis brings over 35 years of health IT expertise, including founding TriZetto. He will guide strategic investments and advance innovation, particularly in artificial intelligence. This move strengthens XiFin's leadership.

The XiFin Empower platform unifies automation, data analytics, and AI. Consequently, it streamlines revenue cycle workflows and improves financial performance. The platform connects patients, providers, and payors across the health ecosystem. Competitors like Waystar and Optum also operate in the revenue cycle management space.

XiFin is uniquely positioned to modernize AI-driven RCM.